Bharat Biotech announces COVAXIN® capacity expansion to support vaccination campaigns in India and worldwide

Bharat Biotech on April 20 announced the COVAXIN capacity expansion to support vaccination campaigns in India and worldwide amid the surge in COVID-19 cases.

The capacity expansion has been implemented across multiple facilities in Hyderabad and Bangalore, to reach over 700 million doses per year, which are one of the largest production capacities for inactivated viral vaccines worldwide

Leave a Reply

Your email address will not be published. Required fields are marked *